Omar Sims. Assistant Professor
Humanities Building 301C1
(205) 934 3268

Research and Teaching Interests: Public Health Management and Clinical Management of Hepatitis C Virus (HCV) and HIV/HCV Co-infection; Liver Disease; Infectious Disease; Concomitant Alcohol Use and Liver Disease

Office Hours: Please email for an appointment

Secondary Appointments:

  • AB, University of Georgia
  • MSW, University of Georgia
  • PhD, University of Georgia

Dr. Omar Sims’ program of research is focused on public health management and clinical management of liver disease caused by hepatitis C virus (HCV) infection in mono-infected and HCV/HIV co-infected patients. HCV is the leading cause of cirrhosis, hepatocellular carcinoma, and liver transplantation in the United States and in most of the western world. Likewise, liver disease caused by HCV is the leading non-AIDS cause of death among those with HIV infection.

His goal in this arena is to publish clinical and translational research to help health professionals improve health outcomes and extend life of those burdened with chronic HCV-associated liver disease. He aims to accomplish this by focusing his research efforts on populations heavily burdened with HCV, but often under-researched or under-represented in liver research: HCV-infected persons with co-existing alcohol, substance use, and psychiatric disorders, HCV/HIV co-infected persons, African Americans living with HCV, and individuals aging with HCV. Similarly, his research efforts include HCV testing among high prevalent populations (who are unaware of their HCV infection), alcohol use reduction among HCV mono-infected and HCV/HIV co-infected patients, and barriers to care.

  • Human Behavior in the Social Environment
  • Social Work Research
  • Guo, Y, & Sims, O.T. (2017). Assessment of recent hiv testing and predictors and barriers associated with testing among older adults in the united states. Social Work in Health Care, e1-e11,
  • North, C. S., Pollio, D. E., Sims, O. T., & Hong, B. A. (2017a). Prospective longitudinal substance use patterns in patients preparing for hepatitis C treatment. Journal of Dual Diagnosis, 16, 1–10.
  • North, C. S., Pollio, D. E., Sims, O. T., Jain, M. K., Brown, G. R., Downs, D. L., et al. (2017b). An effectiveness study of group psychoeducation for hepatitis C patients in community clinics. European Journal of Gastroenterology and Hepatology, 29(6), 679–685.
  • Sims, O. T., Pollio, D. E., Hong, B. A., & North, C. S. (2017). Racial disparities in hepatitis C treatment eligibility. Annals of Hepatology, 16(4), 530–537.
  • Sims, O.T., Guo, Y., Shoreibah, M.G., Venkata, K., Fitzmorris, P., Kommineni, V., Romano, J., & Massoud, O.I. (2017). Alcohol and Substance Use, Race, and Insurance Status Predict Non-Treatment for HCV in the Era of DAAs: A Retrospective Study in a Large Urban Tertiary Center. European Journal of Gastroenterology & Hepatology, 29(11), 1219-1222. doi: 10.1097/MEG.0000000000000961
  • Sims, O.T., Hilgeman, M., Standfield, H., Womack, B.G., & Maynard, Q. (2017). Prevention of suicide among older adults. The Deep South CME Network.
  • North, C.S., Pollio, D.E., Sims, O.T., Jain, M.K., Brown, G., Lisker-Melman, M., & Hong, B.A. (in press). An effectiveness study of group psychoeducation for hepatitis c patients in community clinics. European Journal of Gastroenterology & Hepatology.
  • Guo, Y., & Sims, O.T. (2017). HCV health policy developments in response to the national viral hepatitis action plan: A systematic review. Social Work in Public Health, 17; 32(2), 77-81. doi: 10.1080/19371918.2016.1188745.
  • Sims, O.T., Maynard, Q.R., & Melton, P.A. (2016). Behavioral interventions to reduce alcohol use among hepatitis c patients: A systematic review. Social Work in Public Health, e1-e9. doi: 10.1080/19371918.2016.1160346
  • Sims, O.T., Pollio, D.E., Hong, B.A., Jain, M.K., & Brown, G. (2016). An assessment of concurrent drug and alcohol use among patients seeking treatment for hepatitis c. Annals of Clinical Psychiatry, 28(1), 31-36.
  • Sims, O.T. & Womack, B.G. (2015). Hepatitis C and HIV co-infection for social workers in public health, medical, and substance use treatment settings. Social Work in Public Health, 1-11. doi: 10.1080/19371918.2014.1000506.
  • North, C.S., Sims, O., Hong, B.A., Jain, M.K., Brown, G., Lisker-Melman, M., & Pollio, D.E. (2014). An empirical study of alcohol consumption by patients considering HCV treatment. The American Journal of Drug and Alcohol Abuse, e1-e6. doi: 10.3109/00952990.2014.945592.
  • Sims, O.T., Whalen, C. C., Nackerud, L. G., & Bride, B. E. (2014). Longitudinal effects of selective serotonin reuptake inhibitor therapy and cytokine-related depression on hepatitis C viral logs during antiviral therapy. Journal of Clinical Psychopharmacology, 34(1), 80-84. doi: 10.1097/JCP.b013e3182a47397.
  • Sims, O.T., Whalen, C. C., Nackerud, L. G., & Bride, B. E. (2013). Birth cohort testing for hepatitis C virus: Implications for clinical social workers in health care settings. Social Work in Health Care, 52(8), 689-703. doi: 10.1080/00981389.2013.806385.
  • American Association for the Study of Liver Diseases (AASLD)
  • American Public Health Association (APHA)
  • NIDDK’s Network of Minority Health Research Investigators (NMRI)
  • Society for Social Work and Research (SSWR)
  • Council on Social Work Education (CSWE)
  • American College of Gastroenterology (ACG)